SUZHOU, China and ROCKVILLE, Md., July 14, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company recently dosed the first patient successfully in a Phase I clin

LOS ANGELES, July 14, 2019 /PRNewswire/ -- New research reported at the Alzheimer's Association International Conference (AAIC) 2019

LOS ANGELES, July 14, 2019 /PRNewswire/ -- Two studies reported at the Alzheimer's Association International Conference (

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2019 LOS ANGELES, July 14, 2019 /PRNewswire/ -- New research reported at the Al

STOCKHOLM, July 14, 2019 /PRNewswire/ -- While details of these developments are currently confidential, both companies' intention is to deliver both improved integration and entirely new capabilities to radiation oncology professionals, to help enhance workflow and improve clinical decision-making.Vision RT and RaySearch make natural partners as their activities

INDIANAPOLIS, July 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the presentation of data about personal attitudes toward migraine among people without the disease.1 These data are from the OVERCOME (Observational Survey of the Epidemiology, Treatment and C

BEIJING, June 13, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces that the National Medical Products Administration (NMPA) has approved its investigational new drug (IND) application for TJC4, a differentiat

NUTLEY, N.J., July 12, 2019 /PRNewswire/ -- Hackensack Meridian School of Medicine at Seton Hall University, New Jersey's first private medical school in decades, is proud to announce that it has welcomed its second class of 91 students today, who were selected from nearly 5,000 applicants.

NEW YORK, July 12, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Heron Therapeutics, Inc. ("Heron") or the ("Company") (NASDAQ:HRTX) of the August 5, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

NEW YORK, July 12, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. (Ra Medical or the "Company") (NYSE:RMED) of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.